Uncover key drivers, emerging technologies, and competitive movements shaping the comprehensive metabolic panel (cmp) testing market from 2026–2035 with trusted insights from The Business Research Company
What upper market value could the Comprehensive Metabolic Panel (CMP) Testing Market reach by 2030 starting from 2026 levels?
The comprehensive metabolic panel (cmp) testing market size has experienced significant growth in recent years. This market is forecast to increase from $18.34 billion in 2025 to $19.94 billion in 2026, registering a compound annual growth rate (CAGR) of 8.7%. The historical growth in this sector is attributable to the rising prevalence of chronic diseases, the expansion of diagnostic laboratory networks, the increasing use of blood chemistry testing, improved access to routine health screening, and a growing awareness of preventive diagnostics.
The comprehensive metabolic panel (CMP) testing market is projected to experience substantial expansion in the coming years. Its valuation is set to reach $28.57 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.4%. This anticipated growth during the forecast period is largely due to factors such as a heightened need for swift diagnostic methods, the proliferation of decentralized testing approaches, greater uptake of integrated laboratory automation, an increasing emphasis on population health screenings, and escalating investments in diagnostic infrastructure. Significant trends identified for this period encompass the increasing integration of automated clinical chemistry analyzers, a growing requirement for routine metabolic screening, the expanding implementation of laboratory information systems, the broader availability of point-of-care CMP testing, and a sharpened focus on early disease identification.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12362&type=smp
Which Drivers Are Influencing Long-Term Growth In The Comprehensive Metabolic Panel (CMP) Testing Market?
The comprehensive metabolic panel (CMP) testing market is projected to expand due to the rising occurrence of cardiovascular diseases and diabetes. Cardiovascular disorders, which impact the heart or blood vessels, are linked to atherosclerosis, characterized by the accumulation of fatty deposits within the arteries. Diabetes is a condition that develops when blood glucose levels become excessively high. Comprehensive metabolic panel (CMP) blood tests are designed to detect glucose levels. Consequently, the increasing instances of diabetes and cardiovascular diseases will boost the market’s growth by increasing the demand for diagnostic blood tests such as the CMP blood test. For example, in October 2024, data from the Centers for Disease Control and Prevention, a US-based government agency, indicated that in 2023, cardiovascular disease resulted in 919,032 fatalities, representing one in every three deaths. Coronary heart disease remained the most prevalent form of heart disease, and significantly, about one in six deaths from cardiovascular diseases occurred among adults younger than 65 years. Therefore, the growing prevalence of cardiovascular diseases and diabetes is propelling the growth of the comprehensive metabolic panel (CMP) testing market.
Which Segments Are Driving Activity In The Comprehensive Metabolic Panel (CMP) Testing Market?
The comprehensive metabolic panel (cmp) testing market covered in this report is segmented –
1) By Disease: Kidney Disease, Liver Disease, Diabetes, Other Diseases
2) By Test Type: Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose
3) By End User: Laboratories, Point Of Care (PoC)
Subsegments:
1) By Kidney Disease: Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI), Glomerulonephritis
2) By Liver Disease: Hepatitis (Viral And Non-Viral), Cirrhosis, Fatty Liver Disease
3) By Diabetes: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes
4) By Other Diseases: Cardiovascular Diseases, Electrolyte Imbalances, Metabolic Disorders, Pancreatic Diseases
Which Trends Are Expected To Influence The Comprehensive Metabolic Panel (CMP) Testing Market In The Upcoming Years?
Leading companies in the Comprehensive Metabolic Panel (CMP) testing market are concentrating on developing advanced solutions, such as integrated clinical chemistry and immunoassay analyzers, to deliver faster, more efficient, and consolidated CMP testing workflows. These integrated systems are single, combined platforms that perform both chemistry and immunoassay tests, which helps laboratories accelerate testing, reduce manual steps, and consolidate CMP and related panels for enhanced workflow efficiency and rapid results. For instance, in July 2023, Siemens Healthineers AG, a Germany-based medical technology company, launched the Atellica CI Analyzer, an integrated clinical chemistry and immunoassay system specifically designed for labs needing compact, high-quality CMP workflows. The Atellica CI Analyzer is a modular, random-access platform that pairs chemistry and immunoassay capabilities within a single footprint, supports an extensive and expanding assay menu, and leverages digitized workflows and advanced reporting to improve turnaround times and sample traceability. It incorporates automated sample management and priority testing, built-in diagnostics and IT connectivity for LIS/HIS integration, and an assay development pipeline, allowing labs to consolidate CMP testing and related panels on one system, which enables faster clinician decision-making and requires less hands-on time compared to routing samples across multiple instruments.
Which Key Players Are Driving Competition In The Comprehensive Metabolic Panel (CMP) Testing Market?
Major companies operating in the comprehensive metabolic panel (cmp) testing market are Abbott Laboratories Inc., Siemens Healthineers AG, Mayo Clinic, Laboratory Corporation of America Holdings, Mercy, Mount Sinai Health System, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Hologic Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Werfen SA, DiaSorin S.p.A., Randox Laboratories Ltd., ARUP Laboratories Inc., Invitae Corporation, Abaxis Inc., Metropolis Healthcare Limited, Clinical Reference Laboratory (CRL), Centogene AG, Spectra Laboratories, Unipath Systems Ltd., Scion Lab Services LLC, Weldon Biotech Pvt Ltd., Corona Pathology,Ulta Lab Tests LLC, Any Lab Test Now, Applied InGENuity Diagnostics LLC, Walk-In Lab LLC
Access The Complete Report For Deeper Market Insights:
How Does The Comprehensive Metabolic Panel (CMP) Testing Market Perform Across Major Global Regions?
North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the comprehensive metabolic panel (cmp) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Comprehensive Metabolic Panel (CMP) Testing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12362&type=smp
Browse Through More Reports Similar to the Global Comprehensive Metabolic Panel (CMP) Testing Market 2026, By The Business Research Company
Fully Automatic Biochemistry Analyzer Market Report 2026
Lipid Panel Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report
Biopharmaceutical Cmo Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model